TCL Archive In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982 June 11, 1982
TCL Archive Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase September 30, 1983
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. April 9, 2010
TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
